Healthcare -
Biotechnology - NASDAQ - US
$ 12.69
1.2 %
$ 475 M
Market Cap
8.81
P/E
Price Target
Average
49.72%
Revenue Forecast
Estimate
33.18%
EBIT
Estimate
328.42%
Net Income
Estimate
--186.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Entrada Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TRDA of $19 , with forecasts ranging from
a
low of
$18 to a high of $20 .
TRDA Lowest Price Target
Wall Street Target
18 USD
41.84%
TRDA Average Price Target
Wall Street Target
19 USD
49.72%
TRDA Highest Price Target
Wall Street Target
20 USD
57.60%
REVENUE FORECAST
Revenue Forecast Chart TRDA
EBIT FORECAST
EBIT Forecast Chart TRDA
NET INCOME FORECAST
Net Income Chart TRDA